FDA Is “Open-Minded” On Developing Generic Biologics Guidance
Executive Summary
FDA will stay "open-minded" to suggestions on how to develop generic biologics, Acting Commissioner Lester Crawford, PhD, said at a Senate hearing
You may also be interested in...
FDA Generic Biologics “Structure” To Come Soon; Policy Debate In 2005
FDA hopes to be in a position to kick off a legislative and policy debate on the feasibility of "follow-on" biologics by the beginning of 2005
BIO Government Relations VP Cohen Moving To PodestaMattoon
Biotechnology Industry Organization VP-Government Relations Sharon Cohen is joining the lobbying firm of PodestaMattoon
FDA Generic Biologics “Structure” To Come Soon; Policy Debate In 2005
FDA hopes to be in a position to kick off a legislative and policy debate on the feasibility of "follow-on" biologics by the beginning of 2005